The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
Fibrosis is a chronic and progressive disorder characterized by excessive deposition of extracellular matrix, which leads to scarring and loss of function of the affected organ or tissue. Indeed, the fibrotic process affects a variety of organs and tissues, with specific molecular background. Howeve...
Main Authors: | Jacopo Di Gregorio, Iole Robuffo, Sonia Spalletta, Giulia Giambuzzi, Vincenzo De Iuliis, Elena Toniato, Stefano Martinotti, Pio Conti, Vincenzo Flati |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2020.607483/full |
Similar Items
-
β-Catenin/Smad3 Interaction Regulates Transforming Growth Factor-β-Induced Epithelial to Mesenchymal Transition in the Lens
by: Aftab Taiyab, et al.
Published: (2019-04-01) -
The Epithelial-to-Mesenchymal Transition-Like Process Induced by TGF-β1 Enhances Rubella Virus Binding and Infection in A549 Cells via the Smad Pathway
by: Ngan Thi Kim Pham, et al.
Published: (2021-03-01) -
TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
by: Evangelia Pardali, et al.
Published: (2017-10-01) -
C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells
by: Huanhuan Ji, et al.
Published: (2020-07-01) -
The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis
by: Xia Yao, et al.
Published: (2020-09-01)